Cargando…
Cangrelor ameliorates CLP-induced pulmonary injury in sepsis by inhibiting GPR17
BACKGROUND: Sepsis is a common complication of severe wound injury and infection, with a very high mortality rate. The P2Y12 receptor inhibitor, cangrelor, is an antagonist anti-platelet drug. METHODS: In our study, we investigated the protective mechanisms of cangrelor in CLP-induced pulmonary inju...
Autores principales: | Luo, Qiancheng, Liu, Rui, Qu, Kaili, Liu, Guorong, Hang, Min, Chen, Guo, Xu, Lei, Jin, Qinqin, Guo, Dongfeng, Kang, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262027/ https://www.ncbi.nlm.nih.gov/pubmed/34229761 http://dx.doi.org/10.1186/s40001-021-00536-4 |
Ejemplares similares
-
Efficacy of Cangrelor as Bridging Therapy Post PCI
por: Khan, Abdul A., et al.
Publicado: (2020) -
Feasibility and safety of cangrelor in patients with suboptimal P2Y(12) inhibition undergoing percutaneous coronary intervention: the Dutch Cangrelor registry
por: Selvarajah, Abi, et al.
Publicado: (2021) -
The Heat Shock Protein 70 Plays a Protective Role in Sepsis by Maintenance of the Endothelial Permeability
por: Yuan, Xiaoyan, et al.
Publicado: (2020) -
Cangrelor: Clinical Data, Contemporary Use, and Future Perspectives
por: De Luca, Leonardo, et al.
Publicado: (2021) -
Feasibility and safety of cangrelor in patients with suboptimal P2Y(12) inhibition undergoing percutaneous coronary intervention: rationale of the Dutch Cangrelor Registry
por: Selvarajah, A., et al.
Publicado: (2021)